Production and prophylactic efficacy study of human papillomavirus-like particle expressing HPV16 L1 capsid protein

Journal of Microbiology

Volumn 40, Issue 4, 2002, Pages 313-318

  Park, Jie Yun ^a   Pyo, Hyun Mi ^a   Yoon, Sun Woo ^a   Baek, Sun Young ^b   Park, Sue Nie ^b   Kim, Chul Joong ^c   Poo, Haryoung ^a  

^a Korea Research Institute of Bioscience and Biotechnology (KRIBB)   (South Korea)

^b Korea Food and Drug Administration   (South Korea)

^c Chungnam National University   (South Korea)

Author keywords

Capsid protein; Hemagglutination inhibition; Human papillomavirus (HPV)

Indexed keywords

CAPSID PROTEIN; VACCINE;

ARTICLE; BIOTRANSFORMATION; CELLULAR IMMUNITY; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL FILTRATION; HEMAGGLUTINATION INHIBITION; HUMAN; HUMORAL IMMUNITY; IMMUNIZATION; MOUSE; MOUSE STRAIN; NONHUMAN; PROPHYLAXIS; PROTEIN EXPRESSION; PROTEIN PURIFICATION; SACCHAROMYCES CEREVISIAE; VACCINATION; VERRUCA VULGARIS; VIRUS EXPRESSION; VIRUS INFECTION; WART VIRUS; WESTERN BLOTTING; YEAST;

ANIMALIA; HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPES; MIRIDAE; SACCHAROMYCES CEREVISIAE; VERRUCA; VERRUCA VULGARIS VIRUS;

EID: 0036961835     PISSN: 12258873     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Breitburd, F., and P. Coursaget. 1999. Human papillomavirus vaccines. Seminars in Cancer Biol. 9, 431-445.
2. Buonamassa, D.T., C.E. Greer, S. Capo, T.S.B. Yen, C.L. Galeotti, and G. Bensi. 2002. Yeast coexpression of human papillomavirus types 6 and 16 capsid protein. Virology 293, 335-344.
3. Carter, J.J., N. Yaegashi, S.A. Jenison, and D.A. Galloway. 1991. Expression of human papillomavirus proteins in yeast Saccharomyees Cerevisiae. Virology 182, 513-521.
4. Cho, C.W., Y.S. Cho, B.T. Kang, J.S. Hwang, S.N. Park, and D.Y. Yoon 2001. Improvement of gene transfer to cervical cancer cell lines using non-viral agents. Cancer Lett. 162, 75-85.
5. Evans, T.G., W. Bonnez, R.C. Rose, S. Koenig, L. Demeter, J.A. Suzich, D. O'Brien, M. Campbell, W.I. White, J. Balsley, and R.C. Reichman. 2001. A Phase 1 study of a recombinant virus-like particle vaccine against human papillomavirus type 11 in healthy adult volunteers. J. Infect. Dis. 183(10), 1485-93.
6. Gerber, S., C. Lane, D.M. Brown, E. Lord, M. Dilorenzo, J.D. Clements, E. Rybicki, A.L. Williamson, and R.C. Rose. 2001. Human papillomavirus virus-like particles are efficient oral immunogens when coadministered with Escherichia coli heat-labile Enterotoxin Mutant R192G or CpG DNA. J. Virol. 4752-4760.
7. Hagensee, M.E., N. Yaegashi, and D.A. Galloway. 1993. Self-assembly of human papillomavirus type 1 capsids by expression of the L1 protein alone or by oexpression of the L1 and L2 capsid proteins. J. Virol. 67, 315-322.
8. Harro, C.D., Y.S. Pang, R.B.S. Roden, A. Hildesheim, Z. Wang, M.J. Reynolds, T.C. Mast, R. Robinson, B.R. Murphy, R.A. Karron, J. Dillner, T. Schiller, and D.R. Lowy. 2001. Papillomavirus 16 L1 virus-like paticle vaccine. J. Natl. Cancer Inst. 93(4), 284-292.
9. Jansen, K.U., M. Rosolowsky, L.D. Schultz, H.Z. Markus, J.C. Cook, J.J. Donnelly, D. Martinez, R.W. Ellis, and A.R. Shaw. 1995. Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine 13, 1509-1514.
10. Le Buanec, H., A. Lachgar, R. D'Anna, J.F. Zagury, B. Bizzini, J. Bernard, D. Ittele, S. Hallez, C. Giannouli, A. Burny, and D. Zagury. 1999. Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein. Biomed. Pharmacother. 53, 323-328.
11. Lenz, P., P.M. Day, Y.S. Pang, S.A. Frye, P.N. Jensen, D.R. Lowy, and J.T. Schiller. 2001. Papillomavirus-like particles induce acute activation of dendritic cells. J. Immunol. 2001, 166, 5346-5355.
12. Lowy, D.R., R. Kirnbauer, and J.T. Schiller. 1994. Genital human papillomavirus infection. Proc. Nalt. Acad. Sci. USA. 91, 2436-2440.
13. Roden, R.B.S., N.L. Hubbert, R. Kirnbauer, N.D. Christensen, D.R. Lowy, and J.T. Schiller. 1996. Assessment of the serological relatedness of genital human papillomaviruses by hemagglutination inhibition. J. Virol. 1996, 3298-3301.
14. Roden, R.B.S., W.H. Yutzy, R. Fallon, S. Inglis, D.R. Lowy, and J.T. Schiller. 2000. Minor Capsid protein of human genital papillomaviruses contains subdominant, cross-neutralizing epitopes. Virology 270, 254-257.
15. Rossi, J.L., L. Gissmann, K. Jansen, and M. Muller. 2000. Assembly of human papillomavirus type 16 pseudovirions in Saccharomyces cerevisiae. Hum. Gene Ther. 11, 1165-1175.
16. Schiller, J.T., and A. Hidesheim. 2000. Developing HPV virus-like particle vaccines to prevent cervical cancer: a progress report. J. Clinic. Virol. 19, 67-74.
17. Schiller, J.T., and D.R. Lowy. 1996. Papillomavirus-like particles and HPV vaccine development. Seminars in Cancer Biol.. 7, 373-382.
18. Teresita, S., J. Perez, M.C. Fresan, V. Flores, L. Jimenez, U. Hernandez, I. Herrera, and C. Eslava. 2002. Histological alteration and immune response induced by pet toxin during colonization with enteroaggregative Escherichia coli (EAEC) in a mouse model infection. J. Microbiol. 40, 91-97.
19. Yoon, C.S., K.D. Kim, S.N. Park, and S.W. Cheong. 2001. Alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Biochem. Biophys. Res. Commun. 283(3), 668-73.
20. Zhou, J., X.Y. Sun, H. Davies, L. Crawford, D. Park, and I.H. Frazer. 1992. Definition of linear antigenic regions of the HPV16 L1 capsid protein using synthetic virion-like particles. Virology 189, 592-599.